EVENT SITE
WMIF MAIN SITEActing Chief Academic Officer, Mass General Brigham; Professor of Medicine, HMS
Chief Digital Health Physician, MITRE
CFO, 2seventy bio
CEO, Orna Therapeutics
CEO, Tempest Therapeutics
CEO, AlloVir
CEO, MassChallenge
Senior Vice President and Chief Medical Officer CVS Health
Co-Founder & CTO, Mammoth Biosciences
Chief Innovation Officer, Mass General Brigham
Co-CEO, Amylyx Pharmaceuticals
EVP and Chief Scientific Officer, REGENXBIO
CEO, Acadia Pharmaceuticals
Chief Scientific Officer & President, Worldwide Research, Development and Medical, Pfizer
Chief Financial Officer, Mass General Brigham
Chief Commercial Officer, Moderna
President & CEO, Anokion
Founder, CEO & CIO, GordonMD Global Investments
President & CEO, Sana Biotechnology
CEO, Affimed
CEO, Third Harmonic Bio
CEO, Boundless Bio
CEO & Founder, DICE Therapeutics
CEO, ROME Therapeutics
Founder, President & CEO, Sapience Therapeutics
CEO, Celsius Therapeutics
Co-CEO, Amylyx Pharmaceuticals
President & CEO, Mass General Brigham
Chief Information Officer and Senior Vice President, Digital, Mass General Brigham Associate Professor of Emergency Medicine, HMS
President & CEO, Imunon
President & CEO, ADARx Pharmaceuticals
Chief Corporate Development & Strategy Officer, Alnylam
CEO, Merus
President & CEO, Vigil Neuroscience
CEO, Notch Therapeutics
CEO, BioXcel Therapeutics
CEO, Q32 Bio
Chair & CEO, Bank of America
CEO, Nuvalent
Chief Scientific Officer, McLean Hospital; Professor of Psychiatry, HMS
President & CEO, Cognition Therapeutics
Chief Strategy Officer, BioNTech
Chair & CEO, Eli Lilly and Company
CEO & Co-Founder, QurAlis
Chief Financial Officer, UC Davis Health
Chief Scientific Officer, Verge Genomics
President & CEO, AvenCell Therapeutics
CEO & Co-Founder, Compass Therapeutics
CEO, IGM Biosciences
President & CEO, Lyell
Executive Vice President, Chief Scientific Officer, Intellia Therapeutics
Co-Founder & CEO, Hippocratic AI
President & CEO, Abata Therapeutics
Co-CEO, Thomas H. Lee Partners; Chairman of the Board, Mass General Brigham
Co-Founder & CEO, Endpoint Health
CEO, Chroma Medicine
CEO, LEXEO Therapeutics
CEO, Matchpoint Therapeutics
President & CEO, Biogen
President & CEO, Kura Oncology
Frank Wilkens Jr and Family Endowed Scholar in AD Research, MGH; Assistant Professor of Neurology, HMS
Atlantic Charter Director of the Discovery Center for Musculoskeletal Recovery, Schoen Adams Research Institute, Spaulding Rehabilitation Hospital; Faculty, HMS
Acting Chief Academic Officer, Mass General Brigham; Professor of Medicine, HMS
Lancer Endowed Chair of Dermatology; Director, Wellman Center for Photomedicine, MGH; Professor of Dermatology, HMS
Chief Digital Health Physician, MITRE
Director, Alzheimer’s Clinical & Translational Research Unit, Translational Neurology Head & Managing Director, Interdisciplinary Brain Center, MGH; Professor of Neurology, HMS
Associate Bioengineer, BWH; Associate Professor of Medicine, HMS
Vice President Clinical Research, BWH; Professor, HMS
CFO, 2seventy bio
CEO, Orna Therapeutics
Physician, BWH; Associate Professor, HMS
Neurologist/ALS Clinical Researcher, MGH; Associate Professor, HMS
Managing Director, Healthcare Investment Banking, BofA Securities
CEO, Tempest Therapeutics
CEO, AlloVir
Managing Director, Global Research, BofA Securities
Principal, BGR Group
President, Mass General Hospital; MGH Trustees Professor of Emergency Medicine, HMS
CEO, MassChallenge
Managing Director, Co-Head, North American Healthcare Investment Banking, Head of Life Sciences Investment Banking, BofA Securities
Commissioner, US Food and Drug Administration
Professor of Radiology, University of Michigan
Senior Vice President and Chief Medical Officer CVS Health
Pathologist and Principal Investigator, BWH; Associate Professor of Pathology, HMS
President, Massachusetts, Bank of America
Co-Founder & CTO, Mammoth Biosciences
Managing Director, Senior Equity Research Analyst, BofA Securities
Equity Research Associate, BofA Securities
Chief Innovation Officer, Mass General Brigham
Co-CEO, Amylyx Pharmaceuticals
Director, Lupus Program, BWH; Professor of Medicine, HMS
Chair, Department of Neurology, MGH; Julieanne Dorn Professor of Neurology, HMS
EVP and Chief Scientific Officer, REGENXBIO
CEO, Acadia Pharmaceuticals
Director, High Risk Skin Cancer Clinic, MGH; MGH Research Scholar; Associate Professor, HMS
General Partner, The Engine
Director, Lab of Medical Imaging and Computation, Mass General Brigham; Assistant Professor, HMS
Surgeon-in-Chief, BWH; Moseley Professor of Surgery, HMS
Chief Scientific Officer & President, Worldwide Research, Development and Medical, Pfizer
Associate Pediatrician, Mass General for Children; Assistant Professor of Pediatrics, HMS
Principal Investigator, Wellman Center for Photomedicine, MGH; Associate Professor, HMS
Chair of Psychiatry, MGH; Slater Family Professor of Psychiatry, HMS
Radiologist, Physician-Scientist, MGH; Associate Professor of Radiology, HMS
Director of Clinical Research, Mass General Cancer Center; Professor of Medicine, HMS
Partner, Atlas Venture
Vice President, Strategic Innovation Leaders, Mass General Brigham Innovation
SVP, Business Development and Corporate Strategy, Moderna
Founder & General Partner, Mission BioCapital; Co-Founder & President, LabCentral; CEO, BioLabs
Chief Financial Officer, Mass General Brigham
Head of US Economics Research, Bank of America
Chief Commercial Officer, Moderna
Physician-Scientist, Wellman Center for Photomedicine, MGH; Associate Professor of Dermatology, HMS
President & CEO, Anokion
Biopharma Equity Research Analyst, Bank of America
Co-Director of the Institute for Technology in Psychiatry, President of the Many Brains Project, McLean Hospital; Associate Professor of Psychiatry, HMS
Founder, CEO & CIO, GordonMD Global Investments
Former Commissioner, Food and Drug Administration (2017-2019)
Chief of Rheumatology, Inflammation, and Immunity, BWH; Theodore Bevier Bayles Professor of Medicine, HMS
Neurologist, BWH; Professor of Neurology, HMS
Director, Mass General Cancer Center; Kurt J. Isselbacher Professor of Oncology, HMS
Director, Gene & Cell Therapy Institute Mass General Brigham
Vice President, Global Research, BofA Securities
Secretary of Economic Development, Commonwealth of Massachusetts
Principal, Health & Digital, Oliver Wyman
President & CEO, Sana Biotechnology
Vice President, Global Research, BofA Securities
Governor of the Commonwealth of Massachusetts
CEO, Affimed
CEO, Third Harmonic Bio
CEO, Boundless Bio
Senior Vice President, Network for Excellence in Health Innovation (NEHI)
Director, Neuroregeneration Research Institute, McLean Hospital; Professor of Neurology and Neuroscience, HMS
Associate Scientist, Schepens Eye Research Institute of Mass Eye and Ear; Associate Professor of Ophthalmology, HMS
Investigator, Center for Cancer Research, MGH; Assistant Professor of Medicine, HMS
CEO & Founder, DICE Therapeutics
CEO, ROME Therapeutics
Founder, President & CEO, Sapience Therapeutics
CEO, Celsius Therapeutics
Operating Partner & Senior Advisor, The Riverside Company
Senior Vice President, Business Development, Amgen
Senior Vice President, Venture, Business Development and Licensing, Mass General Brigham
Co-CEO, Amylyx Pharmaceuticals
President & CEO, Mass General Brigham
Partner, Bain Capital Life Sciences
Director of Translational and Clinical Research, BWH; Assistant Professor of Anesthesia, HMS
President, The Kraft Group; Chairman, Board of Trustees, MGH
Director, Evergrande Center for Immunologic Diseases, BWH; Samuel L. Wasserstrom Professor of Neurology, HMS
Araminta Broch-Healey Endowed Chair in ALS, MGH; Associate Professor of Neurology, HMS
Chief Information Officer and Senior Vice President, Digital, Mass General Brigham Associate Professor of Emergency Medicine, HMS
President & CEO, Imunon
Chief of Oncodermatology, BHW; Vice Chair of Dermatology, Dana-Farber Brigham Cancer Center; Associate Professor of Dermatology, HMS
SVP, Head of Research, GSK
President & CEO, ADARx Pharmaceuticals
Associate Physician, Department of Rheumatology, Inflammation, and Immunity, BWH; Associate Professor of Medicine and Biomedical Informatics, HMS
Chief Corporate Development & Strategy Officer, Alnylam
CEO, Merus
President & CEO, Vigil Neuroscience
CEO, Notch Therapeutics
Senior Staff Scientist, BWH; Professor of Pathology, HMS
Principal Investigator, MGH Assistant Professor, HMS
Managing Director, Global Research, BofA Securities
Managing Director, Healthcare Investment Banking, BofA Securities
Managing Director, Head of Global Healthcare Investment Banking, BofA Securities
CEO, BioXcel Therapeutics
Chief of Ophthalmology, Mass Eye and Ear and MGH; Ophthalmologist-in-Chief, BWH; David Glendenning Cogan Professor of Ophthalmology, HMS
CEO, Q32 Bio
Chair & CEO, Bank of America
Managing Director, Co-Head of Origination, Americas Equity Capital Markets, BofA Securities
Director-CEVR, Tufts Medical Center
President, Institute for Clinical and Economic Review; Lecturer, Department of Population Medicine, HMS
CEO, Nuvalent
Director, Familial Dementia Neuroimaging Lab and Director, Multicultural Alzheimer’s Prevention Program, MGH; Paul B. and Sandra M. Edgerley MGH Research Scholar; Associate Professor, HMS
Director, Center for Multiple Myeloma, Mass General Cancer Center; Professor of Medicine, HMS
Chief Scientific Officer, McLean Hospital; Professor of Psychiatry, HMS
President & CEO, Cognition Therapeutics
Chief Strategy Officer, BioNTech
Chair & CEO, Eli Lilly and Company
CEO & Co-Founder, QurAlis
Chief Financial Officer, UC Davis Health
Chief Scientific Officer, Verge Genomics
President & CEO, AvenCell Therapeutics
CEO & Co-Founder, Compass Therapeutics
CEO, IGM Biosciences
President & CEO, Lyell
Chief, Reproductive Endocrine Unit, MGH; Professor of Medicine, HMS
Executive Vice President, Chief Scientific Officer, Intellia Therapeutics
Partner, Venrock
Co-Founder & CEO, Hippocratic AI
Vice President, Strategic Innovation Leaders, Mass General Brigham Innovation
President & CEO, Abata Therapeutics
President & Co-Founder, Moveworks
Associate Chief for Research and Director, Center for Precision Psychiatry, Department of Psychiatry, MGH; Tepper Family MGH Research Scholar; Professor of Psychiatry, HMS
Associate Physician, BWH; Associate Professor of Medicine, HMS
Co-Founder & Senior Advisor, Health Advances
Co-CEO, Thomas H. Lee Partners; Chairman of the Board, Mass General Brigham
Co-Founder & CEO, Endpoint Health
CEO, Chroma Medicine
Vice President, Global Research, BofA Securities
Executive Director, Mass General Brigham MESH Incubator; Associate Chair of Innovation & Commercialization, Mass General Brigham Radiology; Strategic Innovation Leader, Mass General Brigham Innovation
Director, Genetics and Aging Research Unit, Co-Director, McCance Center for Brain Health, MGH; Joseph P. and Rose F. Kennedy Professor of Neurology, HMS
Associate Clinical Director for Innovation, Mass General Cancer Center; Associate Professor of Medicine, HMS
Medical Correspondent, CNN
CEO, LEXEO Therapeutics
CEO, Matchpoint Therapeutics
President & CEO, Biogen
Trustees Endowed Scholar in Anesthesia and Alexander Healey Endowed Chair in ALS, Neurology & Anesthesia, Critical Care and Pain Medicine, MGH; Associate Professor, HMS
Director, Harvard Study of Adult Development, MGH; Professor of Psychiatry, HMS
Secretary of Health and Human Services, State of Massachusetts
Director of the Center for Learning Health Systems, BWH; Professor of the Practice of Psychiatry, HMS
Director, Cardio-Rheumatology Clinic, Associate Physician, Prevention Cardiology and Cardiovascular Imaging, BWH; Instructor of Medicine, HMS
Director, Advanced Research Projects Agency for Health
Pediatric Endocrinologist, MGH; Assistant Professor, HMS
President & CEO, Kura Oncology
Vice President, US Biopharmaceutical Equity Research Analyst, BofA Securities
Vice President, Global Research, BofA Securities
Join our email list to receive exclusive offers